NIH-funded research R01 grant

Investigating treatments for post-hemorrhagic hydrocephalus in the brain.

Official title: Targeting the Choroid Plexus-Cerebrospinal Fluid System to Treat Post-Hemorrhagic Hydrocephalus

Funded at Boston Children's Hospital · NIH-11004388 · Data updated 2026-11-12

This study is looking at ways to help premature babies with post-hemorrhagic hydrocephalus, a condition caused by bleeding in the brain, by finding better treatments that improve the balance of fluid in their brains and reduce damage.

More Hydrocephalus research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBoston Children's Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startJanuary 1, 2023
Project endDecember 31, 2027
Funding year2025
Award (this year)$524,532
NIH project number5R01NS129823-03
Project IDNIH-11004388 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include adults who have experienced complications from post-hemorrhagic hydrocephalus or related conditions.

Less likely to help

Patients who do not have a history of brain hemorrhage or hydrocephalus may not receive any benefit from this research.

What this research studies

This research focuses on understanding and treating post-hemorrhagic hydrocephalus (PHH), a condition that can occur in premature infants due to bleeding in the brain. The study aims to explore how the choroid plexus, which produces cerebrospinal fluid (CSF), and macrophages, which help clear blood from the ventricles, can be manipulated to improve CSF balance and reduce brain damage. By examining the mechanisms of CSF production and removal, the research seeks to identify potential therapeutic targets that could alleviate the symptoms of PHH. Patients may benefit from new treatment strategies developed from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for patients suffering from post-hemorrhagic hydrocephalus, potentially reducing neurological deficits.

How similar studies have gone: Other research has shown promise in targeting cerebrospinal fluid dynamics and macrophage activity for treating similar conditions, indicating a potential for success in this approach.

Where this research is happening

  • Boston Children's Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Lehtinen, Maria — Boston Children's Hospital
  • Study coordinator: Lehtinen, Maria

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.